Sansacar, MerveSagir, HelinAkcok, Emel Gencer2021-11-272021-11-27202120212152-26502152-2669https://hdl.handle.net/20.500.12573/1045Sansacar, Merve/0000-0002-1731-5215;eninfo:eu-repo/semantics/closedAccessAmlAcute Myeloid LeukemiaPi3K/Akt/Mtor PathwayHistone Deacetylase InhibitorsHdac InhibitorsCombination TherapyInvestigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia CellsConference Object